TMO
vs
S&P 500
Over the past 12 months, TMO has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's 24% growth.
Stocks Performance
TMO vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
US |
Danaher Corp
NYSE:DHR
|
||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
||
CH |
Lonza Group AG
SIX:LONN
|
||
US |
Agilent Technologies Inc
NYSE:A
|
||
US |
IQVIA Holdings Inc
NYSE:IQV
|
||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
||
US |
Waters Corp
NYSE:WAT
|
||
US |
Illumina Inc
NASDAQ:ILMN
|
Performance Gap
TMO vs S&P 500
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
US |
Danaher Corp
NYSE:DHR
|
||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
||
CH |
Lonza Group AG
SIX:LONN
|
||
US |
Agilent Technologies Inc
NYSE:A
|
||
US |
IQVIA Holdings Inc
NYSE:IQV
|
||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
||
US |
Waters Corp
NYSE:WAT
|
||
US |
Illumina Inc
NASDAQ:ILMN
|
Performance By Year
TMO vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
P
|
PerkinElmer Inc
LSE:0KHE
|
|
US |
Danaher Corp
NYSE:DHR
|
||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
||
CH |
Lonza Group AG
SIX:LONN
|
||
US |
Agilent Technologies Inc
NYSE:A
|
||
US |
IQVIA Holdings Inc
NYSE:IQV
|
||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
||
US |
Waters Corp
NYSE:WAT
|
||
US |
Illumina Inc
NASDAQ:ILMN
|
Competitors Performance
Thermo Fisher Scientific Inc vs Peers
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
US |
G
|
GE Vernova LLC
NYSE:GEV
|
|
NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
|
US |
Schlumberger NV
NYSE:SLB
|
||
US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
|
ID |
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
||
US |
R
|
Reddit Inc
NYSE:RDDT
|
|
CH |
G
|
Galderma Group AG
SIX:GALD
|
|
US |
Halliburton Co
NYSE:HAL
|
||
LU |
Tenaris SA
MIL:TEN
|
||
IN |
Jio Financial Services Ltd
NSE:JIOFIN
|
Thermo Fisher Scientific Inc
Glance View
Thermo Fisher Scientific Inc. stands as a towering entity in the life sciences industry, intricately weaving together science, technology, and business to drive scientific progress and innovation. Founded through a merger of Thermo Electron and Fisher Scientific in 2006, the company has grown exponentially to become a formidable partner for researchers, academicians, and clinicians worldwide. Its business model is built around a broad portfolio of offerings, including laboratory instruments, analytical tools, and consumables, which are crucial for research and quality control. By emphasizing research and development, Thermo Fisher has consistently advanced its technologies, ensuring that its solutions remain indispensable to ventures in pharmaceuticals, biotechnology, and diagnostics. The strategic acquisition of complementary businesses has been a key facet of Thermo Fisher’s growth, fortifying its position across various scientific fields. In essence, the company thrives on understanding the increasingly complex demands of the scientific community. It generates revenue by capitalizing on its diverse product lineup, subscription-based services, and personalized solutions that cater to specific client needs—ranging from equipment used to perform intricate genomic sequencing to reagents required for advanced laboratory experiments. Thus, Thermo Fisher sustains its financial health through a combination of one-time sales and recurring revenue streams, a strategy that not only reflects its adaptability but also ensures long-term profitability and market leadership in the ever-evolving landscape of scientific research.